These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8348568)

  • 1. Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease.
    Curtis MJ; Pugsley MK; Walker MJ
    Cardiovasc Res; 1993 May; 27(5):703-19. PubMed ID: 8348568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by cimetidine, but not ranitidine, implies that H2 receptors do not mediate arrhythmogenesis in a rat model of regional ischaemia and reperfusion in vitro.
    Banning MM; Curtis MJ
    Cardiovasc Res; 1995 Nov; 30(5):705-10. PubMed ID: 8595616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eicosanoids and susceptibility to ventricular arrhythmias during myocardial ischaemia and reperfusion.
    Parratt JR; Coker SJ; Wainwright CL
    J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():55-66. PubMed ID: 3323537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
    Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
    Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rabbit dual coronary perfusion model: a new method for assessing the pathological relevance of individual products of the ischaemic milieu: role of potassium in arrhythmogenesis.
    Curtis MJ
    Cardiovasc Res; 1991 Dec; 25(12):1010-22. PubMed ID: 1806232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiological basis of arrhythmogenesis in myocardial ischemia and reperfusion: possible target for intervention.
    Curtis MJ
    Bratisl Lek Listy; 1991 Feb; 92(2):91-101. PubMed ID: 1851460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism.
    Baker KE; Curtis MJ
    Br J Pharmacol; 2004 May; 142(2):352-66. PubMed ID: 15066909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-arrhythmic effects of myocardial ischaemia. Relation to reperfusion arrhythmias?
    Podzuweit T; Binz KH; Nennstiel P; Flaig W
    Cardiovasc Res; 1989 Feb; 23(2):81-90. PubMed ID: 2550132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
    Flores NA; Goulielmos NV; Seghatchian MJ; Sheridan DJ
    Cardiovasc Res; 1994 Nov; 28(11):1662-71. PubMed ID: 7842460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?
    Sharif I; Kane KA; Wainwright CL
    Cardiovasc Res; 1998 Sep; 39(3):625-32. PubMed ID: 9861305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin and the ischaemic heart.
    Wainwright CL; McCabe C; Kane KA
    Curr Vasc Pharmacol; 2005 Oct; 3(4):333-41. PubMed ID: 16248776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reperfusion induced arrhythmias following ischaemia in intact rat heart: role of intracellular calcium.
    Brooks WW; Conrad CH; Morgan JP
    Cardiovasc Res; 1995 Apr; 29(4):536-42. PubMed ID: 7796448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances.
    Wainwright CL; Parratt JR
    Cardiovasc Res; 1991 Feb; 25(2):93-100. PubMed ID: 1742769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified model of global ischaemia: application to the study of syncytial mechanisms of arrhythmogenesis.
    Ridley PD; Yacoub MH; Curtis MJ
    Cardiovasc Res; 1992 Apr; 26(4):309-15. PubMed ID: 1638559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of endothelin-1 in acute ischaemic arrhythmias in cats and rats.
    Lin L; Yuan WJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():228S-232S. PubMed ID: 12193092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reperfusion damage: free radicals mediate delayed membrane changes rather than early ventricular arrhythmias.
    Coetzee WA; Owen P; Dennis SC; Saman S; Opie LH
    Cardiovasc Res; 1990 Feb; 24(2):156-64. PubMed ID: 2328520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in extracellular potassium concentration during early myocardial ischaemia and reperfusion: implications for arrhythmogenesis.
    Coronel R
    Cardiovasc Res; 1994 Jun; 28(6):770-7. PubMed ID: 7923278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.